Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation Cannabis Investing News
Braxia Scientific Opens First Ketamine Therapy Clinic in Quebec; Enters Joint Venture with Neurotherapy Montreal, A Leading Brain Injury Solutions Clinic for Adults and Children Psychedelics Investing
COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021 Psychedelics Investing
LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Champignon Brands Inc. Investors to Secure Counsel Before Important June 9 Deadline in Securities Class Action - SHRMF Psychedelics Investing
Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering Psychedelics Investing
FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Psychedelics Investing
EBON, DOX & SHRMF Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe PTSD Cannabis Investing News
Seelos Therapeutics to Participate in the 2021 Jefferies Virtual Healthcare Conference Psychedelics Investing
